Showing 2 of 2 results

Wiercińska E et al.
BACKGROUND AND AIM OF THE STUDY: The principles of „cold chain” have been developed for the safe transport and storage of vaccines because of their sensitivity to temperature and are guidelines...
Helen S Marshall et al.
Background Bivalent rLP2086 is a recombinant factor H binding protein-based vaccine approved in the USA for prevention of meningococcal serogroup B disease in 10–25-year-olds. We aimed to assess...